Background
Methods
Study design, participants and specimen collection
Genomic DNA isolation, whole genome sequencing, and analysis
Results
Specimens and isolates
Origin of isolate | Drug susceptibility resultsd | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Isolate | wardb | specimenc | yeara | AMC | AM | CZ | CAZ | CRO | C | CIP | GM | NA | SXT |
4 | MW | Stool | 2013 | S | R | S | S | S | S | S | S | S | R |
5 | MW | Stool | 2013 | S | S | S | S | S | S | S | S | S | S |
6 | MW | Stool | 2013 | S | S | S | S | S | S | S | S | S | S |
10 | SW | Swab | 2013 | R | R | S | S | S | S | R | S | R | S |
21 | MW | Stool | 2013 | R | S | S | S | S | S | S | S | S | R |
22 | MW | Stool | 2013 | N | N | N | N | N | N | N | N | N | N |
30 | SW | Swab | 2013 | S | S | S | S | S | S | S | S | S | S |
44 | SICU | Swab | 2013 | S | R | R | R | R | S | R | R | R | R |
70 | MW | Sputum | 2013 | R | R | R | R | R | S | R | S | R | R |
73 | MW | Stool | 2013 | R | R | R | R | R | S | R | S | R | R |
82 | MW | Stool | 2013 | R | R | R | S | R | S | R | S | R | R |
97 | MW | Stool | 2014 | N | N | N | N | N | N | N | N | N | N |
115 | SW | Swab | 2014 | S | R | R | R | R | S | S | S | S | R |
199 | MW | Blood | 2014 | R | R | R | R | R | R | R | R | R | R |
203 | MW | Stool | 2014 | R | R | S | S | S | S | R | S | R | R |
210 | MW | Blood | 2014 | R | R | R | R | R | S | R | R | R | R |
244 | MW | Sputum | 2014 | R | R | R | R | R | S | R | R | R | R |
245 | MW | Swab | 2014 | R | R | R | R | R | S | R | R | R | R |
247 | MW | Blood | 2014 | R | R | R | S | R | S | R | S | R | R |
298 | MW | Stool | 2014 | N | N | N | N | N | N | N | N | N | N |
365 | SICU | Swab | 2014 | R | R | R | R | R | S | R | S | R | R |
393 | MICU | Stool | 2015 | R | R | R | R | R | S | R | R | R | R |
521 | MW | Sputum | 2014 | S | S | S | S | S | S | S | S | R | R |
538 | SW | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
554 | MW | Stool | 2015 | N | N | N | N | N | N | N | N | N | N |
587 | SW | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
603 | MICU | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
118A | SW | Swab | 2014 | S | R | S | S | S | S | S | S | S | S |
119EC | MW | Stool | 2014 | S | S | R | R | R | R | S | S | S | S |
163A | SW | Swab | 2014 | S | S | S | S | S | S | S | S | S | S |
237C | SW | Swab | 2014 | N | N | N | N | N | N | N | N | N | N |
340B | MW | Sputum | 2014 | S | S | S | S | S | S | S | S | S | R |
431D | SICU | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
567B | SW | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
598A | MW | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
598B | MW | Swab | 2015 | N | N | N | N | N | N | N | N | N | N |
71E | MW | Swab | 2013 | R | R | R | R | R | S | R | R | R | R |
77E | SICU | Swab | 2013 | R | R | R | R | R | S | R | S | R | S |
Multi-locus sequence typing and serotyping
Isolate | STe | Serotype | Virulence Factors | ||||
---|---|---|---|---|---|---|---|
Adherence | Toxin | Protease | Evasiong | Type IIIh | |||
70 | ST-131 | O25:H4 |
Iha,nfaE
|
sat
|
iss
| ||
73 | ST-131 | O25:H4 |
Iha,nfaE
|
sat
|
iss
| ||
199 | ST-131 | O25:H4 |
Iha
|
astA,senB
|
sat
|
iss
| |
210 | ST-131 | O25:H4 |
Iha,nfaE
|
senB
|
sat
|
iss
| |
587 | ST-131 | O25:H4 |
Iha
|
sat
|
iss
| ||
603 | ST-131 | O15:H1 |
iha,nfaE lpfA,eilA
|
senB
|
sat
|
iss
|
air
|
567B | ST-131 | O25:H4 |
Iha
|
sat
|
iss
| ||
71E | ST-131 | O25:H4 |
iha,nfaE
|
senB
|
sat
|
iss
| |
244 | ST-617f | O89:H10 |
iss
| ||||
245 | ST-617 f | O89:H10 |
iss
| ||||
538 | ST-617 f | O89:H10 |
astA,senB
|
iss
|
capU
| ||
237C | ST-617 f | O89:H10 |
iss
| ||||
393 | ST-405 | O102:H6 |
eilA
|
air
| |||
10 | ST-410 | O??:H9 |
lpfA
| ||||
22 | ST-410 | O??:H9 |
lpfA
| ||||
598B | ST-410 | O8:H21 |
lpfA
|
iss
| |||
97 | ST-10 f | O89:H10 | |||||
203 | ST-10 f | O89:H10 | |||||
340B | ST-10 f | O89:H9 |
iss
| ||||
44 | ST-167 f | O89:H21 | |||||
247 | ST-167 f | O89:H9 |
senB
|
iss
|
capU
| ||
5a | ST-226 | O40:H19 |
bfpA,eae
|
espA,espF,espJ
|
nleB,nleC
| ||
6a | ST-226 | O40:H19 |
bfpA,eae
|
espA,espF,espJ
|
nleB,nleC
| ||
118Ad | ST-73 | O6:H1 |
Iha
|
pic
|
sat,vat
|
iss
|
mchB,mchC,mchF,mcmA
|
21 | ST-942 | O39:H28 |
lpfA
|
iss
| |||
554c | ST-95 | O2(50):H4 |
iss
|
mchF
| |||
431D | ST-44 f | O89:H4 | |||||
119EC | ST-4959 | O154:H4 | |||||
521b | ST-504 | O166:H7 |
Iha
|
vat
|
iss
|
mchB,mchC,mchF,mcmA, sigA, capU
| |
4 | ST-2332 | O128:H45 |
cfaC, lngA
|
eatA
| |||
30 | ST-355 | O150:H5 |
pic
|
vat
|
iss
| ||
115 | ST-361 | O9:H30 | |||||
163A | ST-372 | O83:H31 |
vat
|
iss
| |||
298 | ST-38 | O86:H18 |
Iha,nfaE eilA
|
senB
|
sat
|
iss
|
air
|
365 | ST-224 | O8:H23 |
lpfA
|
iss
| |||
82 | ST-156 | O61:H34 |
lpfA
|
iss
| |||
598A | ST-1193 | O75:H5 |
Iha
|
senB
|
sat,vat
| ||
77E | ST-1284 | O89:H21 |
iss
|
Virulence factors
Acquired antimicrobial resistance
Isolate | AMGa | BLb | FQAc | Macrolide | Phenicol | Quinolone | Sulphonamide | Tetracycline | Trimethoprim |
---|---|---|---|---|---|---|---|---|---|
4 |
strA strB
| blaTEM-1B |
sul2
|
dfrA14
| |||||
5 | |||||||||
6 | |||||||||
10 | blaOXA-1 |
aac(6’)Ib-cr
|
catB3
|
tet(A)
| |||||
21 |
strA strB
|
sul2
|
tet(A)
|
dfrA14
| |||||
22 | blaOXA-1 |
aac(6’)Ib-cr
|
catB3
|
tet(A)
| |||||
30 | |||||||||
44 |
aac(3)-IId aadA2
| blaCTX-M-15 blaTEM-1B |
mph(A)
|
catA1
|
QnrS1 qepA QnrD
|
sul1
|
tet(A)
|
dfrA12
| |
70 |
aadA5
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1
|
tet(A)
|
dfrA17
| |
73 |
aadA5
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1
|
tet(A)
|
dfrA17
| |
82 |
strA strB aadA2
| blaTEM-1B |
mph(A)
|
sul2 sul1
|
tet(B) tet(A)
|
dfrA12
| |||
97 | blaOXA-1 |
aac(6’)Ib-cr
|
catB3
|
tet(B)
| |||||
115 |
aadA1 aac(3)-IIa strB strA
| blaCTX-M-15 blaTEM-1B blaOXA-1 |
aac(6’)Ib-cr
|
catB3 catA1
|
QnrB1
|
sul2
|
dfrA14
| ||
163A | |||||||||
199 |
aadA1 strB strA aadA5 aadB
| blaCTX-M-15 blaTEM-1B blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3 cmlA1
|
sul1 sul2
|
tet(A)
|
dfrA17
| |
203 |
strB strA
| blaTEM-1C blaOXA-1 |
aac(6’)Ib-cr
|
catB3
|
sul2
|
tet(A)
|
dfrA14
| ||
210 |
aadA5 aac(3)-IIa strB strA
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1 sul2
|
tet(A)
|
dfrA17
| |
237C |
aac(3)-Iia aadA5 strA strB
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1 sul2
|
tet(B)
|
dfrA17
| |
244 |
aac(3)-IIa aadA5 strA strB
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul2 sul1
|
tet(B)
|
dfrA17
| |
245 |
strA aac(3)-IIa strB aadA5
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1 sul2
|
tet(B)
|
dfrA17
| |
247 |
strA strB aadA5
| blaOXA-1 blaCTX-M-15 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul2 sul1
|
tet(A)
|
dfrA17
| |
298 |
strB strA
| blaTEM-1B |
catA1
|
sul2
|
tet(D)
|
dfrA7
| |||
365 |
aadA5
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1
|
tet(A)
|
dfrA17
| |
393 |
aac(3)-Iia aadA5
| blaCTX-M-15 blaOXA-1 | aac(6’)Ib-cr |
mph(A)
|
catB3
|
sul1
|
tet(B)
|
dfrA17
| |
431D |
erm(B) strA strB
|
sul2
| |||||||
521 |
sul2 sul1
|
dfrA5
| |||||||
538 |
aac(3)-Iia aadA5 strA strB
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1 sul2
|
tet(A) tet(B)
|
dfrA17
| |
554 |
strA strB
| blaTEM-1B |
sul2
|
dfrA5
| |||||
567B |
aadA5
|
mph(A)
|
sul1
|
dfrA17
| |||||
587 |
aadA5
| blaCTX-M-15 |
mph(A)
|
sul1
|
dfrA17
| ||||
603 |
strB aadA5 aac(3)-IId strA
| blaTEM-1B |
mph(A)
|
sul2 sul1
|
dfrA17
| ||||
118A |
strB strA
| blaTEM-1B |
sul1 sul2
|
dfrA7
| |||||
119EC | |||||||||
340B |
strB strA
|
sul2
|
tet(A)
|
dfrA14
| |||||
598A |
strB strA
| blaTEM-1B |
mph(A)
|
sul2
|
tet(B)
|
dfrA17
| |||
598B |
aac(3)-IIa strB strA
| blaTEM-1B blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul2
|
tet(A)
|
dfrA14
| |
71E |
aadA5 aac(3)-IIa strB strA
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
mph(A)
|
catB3
|
sul1 sul2
|
tet(A)
|
dfrA17
| |
77E |
strA strB
| blaCTX-M-15 blaOXA-1 |
aac(6’)Ib-cr
|
catB3
|
sul2
|
tet(B)
|
Phenotype and sequence based antimicrobial resistance comparison
Antibiotic name | DSTa | WGSb | Agreement | Kappa | P value |
---|---|---|---|---|---|
Amoxicillin-Clavulanate | 15 (62.5%) | 14 (58.3%) | 0.875 | 0.74 | 0.0001 |
Ampicillin | 16 (66.7%) | 14 (58.3%) | 0.9167 | 0.82 | 0.00 |
Ceftazidime | 13 (54.2%) | 13 (54.2%) | 0.9167 | 0.83 | 0.00 |
Ceftriaxone | 15 (62.5) | 13 (54.2%) | 0.9167 | 0.84 | 0.00 |
Chloramphenicol | 2 (8.3%) | 2 (8.3%) | 0.8333 | −0.09 | 0.672 |
Ciprofloxacin | 15 (62.5%) | 14 (58.3%) | 0.875 | 0.74 | 0.0001 |
Gentamycin | 7 (29.2%) | 7 (29.2%) | 0.9167 | 0.79 | 0.00 |
Trimethoprim Sulpha | 17 (70.8%) | 4 (16.7%) | 0.4583 | 0.15 | 0.0799 |